(E)-5,6-Dimethoxy-2-{3-[(piperidin-1-yl)methyl]-benzylidene}-2,3-dihydroinden-1-one

ID: ALA475161

PubChem CID: 25197632

Max Phase: Preclinical

Molecular Formula: C24H27NO3

Molecular Weight: 377.48

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1OC)C(=O)/C(=C/c1cccc(CN3CCCCC3)c1)C2

Standard InChI:  InChI=1S/C24H27NO3/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-7-6-8-18(11-17)16-25-9-4-3-5-10-25/h6-8,11-12,14-15H,3-5,9-10,13,16H2,1-2H3/b20-12+

Standard InChI Key:  YUVGMQGHHQRBBC-UDWIEESQSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    8.7897  -20.2762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5441  -20.6096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4593  -21.4319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6491  -21.6002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2366  -22.3160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4116  -22.3160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9991  -21.6002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4116  -20.8885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2366  -20.8885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6173  -19.4660    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.2600  -20.1971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9717  -20.6096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6875  -20.1971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4034  -20.6096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4034  -21.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6875  -21.8471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9717  -21.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1151  -20.1971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8310  -20.6096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.5468  -20.1971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2585  -20.6096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2585  -21.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5468  -21.8471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8310  -21.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1741  -21.6002    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7616  -22.3160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9991  -23.0319    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1741  -23.0319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  1  9  1  0
  4  9  2  0
  1 10  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 19 24  1  0
 18 19  1  0
 14 18  1  0
  2 11  2  0
 25 26  1  0
  7 25  1  0
 27 28  1  0
  6 27  1  0
M  END

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ache Acetylcholinesterase and butyrylcholinesterase (AChE and BChE) (232 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bche Butyrylcholinesterase (745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ache Acetylcholinesterase (2577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 377.48Molecular Weight (Monoisotopic): 377.1991AlogP: 4.51#Rotatable Bonds: 5
Polar Surface Area: 38.77Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.45CX LogP: 4.37CX LogD: 3.29
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.72Np Likeness Score: -0.42

References

1. Sheng R, Xu Y, Hu C, Zhang J, Lin X, Li J, Yang B, He Q, Hu Y..  (2009)  Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives.,  44  (1): [PMID:18436348] [10.1016/j.ejmech.2008.03.003]
2. Chitranshi N, Gupta S, Tripathi PK, Seth PK.  (2013)  New molecular scaffolds for the design of Alzheimers acetylcholinesterase inhibitors identified using ligand- and receptor-based virtual screening,  22  (5): [10.1007/s00044-012-0227-3]

Source